Stefan Milutinovic

Researcher @GallimoreGodkin
Imaging tumor and LN blood vessels with LSFM

[Gallimore Godkin Lab @GallimoreGodkin]

🔬 Interested in AI + cancer research? Come join our lab and CUBRIC for a Fully Funded PhD Studentship (3.5 years or part-time equivalent).

More info below apply here: https://t.co/uje6vkxzu4

[Gallimore Godkin Lab @GallimoreGodkin]

Our article, "Whole blood-based measurement of SARS-CoV-2-specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid-organ cancers," is now a top 10 most-cited paper in @immunology! #TopCitedArticle

[Gallimore Godkin Lab @GallimoreGodkin]

We are excited to share new research from our group! A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4+ T cell activation. @CellReports
https://t.co/jHsRp9CLO1

[Gallimore Godkin Lab @GallimoreGodkin]

Our article 'T Cell Activation Drives Useful Tumour HEV' published in @discovimmunol has been featured in @britsocimm’s #WorldCancerDay Virtual Issue! Catch up on cutting-edge cancer #immunology & #immunotherapy research here: https://t.co/tMLhlX2ISg

[Discovery Immunology Journal @discovimmunol]

We're proud to feature top articles on #tumour antigens, CD8 #Tcell migration, #NKG2D & more! 🙌

Catch up on the latest #cancer research this #WorldCancerDay in this Virtual Issue for ⬇️

[Denis Wirtz @deniswirtz]

Our self-propelled CAR T cells expressing synthetic “velocity” receptors infiltrate pancreatic tumors like its butter (bottom). Control CAR T cells can’t (top).

Game over.

Works in any solid tumor; can transform any CAR T of your choice into a Ferrari.

https://t.co/bfAty2bCtu

[Systems Immunity Research Institute @CUSystemsImmu]

Science Seminar with @fabian_theis on June 15th 3pm BST/4pm CET on Learning and Transferring Cellular State in Single Cell Atlases. Please register at https://t.co/icyzx7De4Z…
@HelmholtzMunich @TU_Muenchen @sangerinstitute
@helmholtz_ai

[Noah Veis Gavil, MD, PhD @Noah_V_Gavil]

Very excited to share our work in @SciImmunology on the migration properties of CD8+ tumor-infiltrating lymphocytes (TILs)! Using 🐭 models and parabiosis, we uncovered unique features of tumor-resident T cells. Spoiler 🚨tumor ≠ healthy tissue. https://t.co/iMVpMDsYPu 1/7

[DimbergLab @DimbergLab]

Curious on how we modified blood vessels to boost immunity and treat brain cancer? 💉🧠 Our new publication is out now on @Cancer_Cell ! Big congrats to the first authors of this work, @mohanraj9706 , @AleVaccaro93 & @tiarnevdw , and to the whole team 🥳 https://t.co/KRgJq3Lo2R

[Gallimore Godkin Lab @GallimoreGodkin]

Read our recent review just published in Discovery Immunology! "The Link between T cell Activation and Development of Functionally Useful Tumour Associated High Endothelial Venules" https://t.co/FRWvZ6hP9B
@paxsm7

[DrewDudleyLab @DrewDudleyLab]

Happy to share our latest collaborative work with @kamm_lab and @ChiappinelliLab @NatureComms where targeting an epigenetic factor in tumor vasculature augments IFN response; blood vessels thus become like "honey to a fly" and permit CD8+ T-cell entry. https://t.co/5TwBdATldV

[Gerlanda Vella @gerlanda_vella]

My first co-first author paper is finally out in @Cancer_Cell!
Check it out to learn about the ontology, regulation, and function of HEVs in cancer!

A big thank to @BergersLab, #YichaoHua, #LizAllen, and our collaborators. @vib_ccb @Onco_KULeuven

https://t.co/R2No5ByPuE

[Gallimore Godkin Lab @GallimoreGodkin]

We are excited to share new research from our group! 3D imaging of HEV dynamics in lymph nodes and tumours during immunotherapy. @CRC_AACR @paxsm7

https://t.co/5aZxOjoMjO

[Florian Jug @florianjug]

Today is the day! @ImarisSoftware releases their version 9.9, prominently featuring Labkit and the ImgLib2-Imaris bridge.
What this means for you, for Imaris, and for @FijiSc you ask?
A mini-🧵…
https://t.co/3LNq8ateLK

[Nature Biomedical Engineering @natBME]

A method for the multimodal volumetric imaging of RNAs and proteins in intact tumour volumes and organoids enables the spatial transcriptional profiling of coding RNAs and non-coding RNAs at single-cell resolution in cancer tissues.

https://t.co/vdjNFP6e41

[Nicholas Sofroniew @sofroniewn]

Who wants us to hook this up to @napari_imaging for 3D visualization of 🔬 data? Looks 🚀

[Gallimore Godkin Lab @GallimoreGodkin]

"Do HEV promote or restrain cancer progression?" - read the paper below by Stefan Milutinovic which has just been published in Trends in Cancer!
@paxsm7 @trendscancer #HEV #Immunology #Cancer

https://t.co/TcgLCqOdqz

[Alan Parker @alanlparker]

Completely agree with every word here 👇🏼👇🏼 there will always be time to catch up with research and experiments. Hard as it is, people matter much more at the present time.